Plastic pollution has become one of the most serious environmental challenges worldwide. Billions of plastic bottles are discarded each year, and most of them end up in landfills or the natural environment. Now, scientists have discovered a surprising way to turn this waste into something valuable. In a new study, researchers have engineered bacteria that can convert chemicals from plastic bottles into a compound used to make drugs for treating Parkinson’s disease.
Breaking Down Plastic Waste
The research focuses on polyethylene terephthalate (PET), the plastic commonly used in beverage bottles and food packaging. Scientists first break PET down into one of its main building blocks, terephthalic acid. Instead of discarding this compound, the researchers feed it into specially engineered bacteria.
These microbes act like microscopic chemical factories. Once the plastic-derived molecules enter the bacterial cells, a series of biological reactions transforms them into levodopa, a key medication used to treat Parkinson’s disease.
From Waste to Essential Medicine
Levodopa is widely considered the most effective treatment for Parkinson’s disease. The drug helps replenish dopamine levels in the brain, which can reduce symptoms such as tremors, stiffness, and slow movement. Traditionally, levodopa is produced through complex industrial chemical processes that rely heavily on petroleum-based materials.
However, the new technique allows bacteria to carry out much of the chemical transformation under mild conditions. As a result, the process could lower energy use and reduce the environmental impact of pharmaceutical manufacturing.
A Step Toward Sustainable Drug Production
Although the method is still being tested in laboratories, the discovery highlights the potential of “upcycling” plastic waste into high-value products. If the technology can be scaled up successfully, plastic bottles that once polluted the environment could become raw materials for producing important medicines.
In the future, such innovations may help address two major global challenges at once—reducing plastic waste while creating more sustainable ways to manufacture life-saving drugs.
